查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1703237

2025年全球冠狀動脈支架市場報告

Coronary Stents Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年冠狀動脈支架市場規模將強勁成長。到 2029 年，這一數字將成長至 165 億美元，複合年成長率為 8.3%。預測期內的成長可歸因於心血管疾病盛行率的上升、人口老化、心血管健康意識的增強、政府援助計劃和資金以及文明病盛行率的上升。預測期內的關鍵趨勢包括支架技術創新、成像技術創新、策略聯盟和夥伴關係關係、支架材料創新以及與數位健康的技術融合。

心血管疾病（CVD）盛行率的上升預計將推動冠狀動脈支架市場的擴張。 CVD 包括一系列心臟和血管疾病，包括冠狀動脈疾病、心臟衰竭、中風和高血壓。心血管疾病的增加是由於人口老化以及肥胖、糖尿病、久坐的生活方式、不良飲食和壓力等風險因素的增加。冠狀動脈支架在心血管疾病的治療中至關重要，因為它們可以打開冠狀動脈的狹窄或阻塞，改善心臟的血液流動並降低心臟病發作的風險。例如，美國心臟學會2022年8月發布的報告預測，2025年至2060年美國心血管危險因子將大幅增加，其中糖尿病患者將增加39.3%至5500萬人，血脂異常症將增加27.6%至1.26億人，高血壓患者將增加25.1%至1.62億人，肥胖患者將增加1.3%。增幅最大的是中風（增加 33.8% 至 1500 萬人）和心臟衰竭（增加 33.4% 至 1300 萬人），缺血性心臟疾病和心臟病發作也大幅增加。心血管疾病盛行率的上升推動了冠狀動脈支架的需求。

冠狀動脈支架市場的公司正專注於開發藥物釋放型支架等先進產品，以盡量減少與傳統裸金屬支架相比再次手術的需要。藥物釋放型支架是一種塗有藥物的特殊裝置，可以緩慢釋放藥物以防止動脈再次變窄。例如，2024年5月，美國醫療保健公司雅培在印度推出了其XIENCE Sierra艾諾莉茉斯冠狀動脈塗藥支架系統。該支架具有增強的設計、新穎的輸送系統和獨特的尺寸選擇，以適應複雜的適應症。與其他XIENCE支架一樣，該支架塗有特殊塗層，可降低動脈再次阻塞的風險，並擁有超過120項臨床試驗（涉及超過120,000名患者）支持的強大安全記錄。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球冠狀動脈支架市場 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球冠狀動脈支架市場：成長率分析
  • 全球冠狀動脈支架市場表現：規模與成長，2019-2024
  • 全球冠狀動脈支架市場預測：規模與成長，2024-2029，2034F
  • 全球冠狀動脈支架總目標市場（TAM）

第6章市場區隔

  • 全球冠狀動脈支架市場：按產品類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 雙療法支架
  • 放射性支架
  • 血栓切除支架
  • 覆膜支架
  • 生物可吸收支架
  • 生物分解性支架
  • 混合支架
  • 藥物釋放型支架
  • 裸金屬支架
  • 全球冠狀動脈支架市場技術、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 雷射切割
  • 3D列印支架
  • 微加工
  • 基於奈米技術的支架
  • 電解拋光
  • 其他技術
  • 全球冠狀動脈支架市場（按原始材料、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 鈷鉻合金
  • 不銹鋼
  • 鉑鉻
  • 鎳鈦合金
  • 聚合物
  • 全球冠狀動脈支架市場：按部署、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 自動擴張型支架
  • 球囊擴張型支架
  • 全球冠狀動脈支架市場最終用途、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 醫院及門診手術中心
  • 專科診所
  • 其他用途
  • 全球冠狀動脈支架市場、雙療法支架類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • Sirolimus洗脫雙療支架
  • 紫杉醇洗脫雙療支架
  • Everolimus洗脫雙療支架
  • 全球冠狀動脈支架市場依放射性支架類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • BETA射線支架
  • 伽瑪射線支架
  • 其他放射性支架
  • 全球冠狀動脈支架市場細分（依血栓切除支架類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 手動血栓切除支架
  • 機械血栓切除支架
  • 動態血栓切除支架
  • 全球冠狀動脈支架市場細分（依覆膜支架類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • PTFE塗層支架
  • ePTFE覆膜支架
  • 聚氨酯塗層支架
  • 其他覆膜支架
  • 全球冠狀動脈支架市場，按生物可吸收支架類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基生物可吸收支架
  • 金屬基生物可吸收支架
  • 陶瓷基生物可吸收支架
  • 全球冠狀動脈支架市場生物分解性支架類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 聚合物生物分解性支架
  • 鎂基生物分解性支架
  • 其他生物分解性支架
  • 全球冠狀動脈支架市場混合支架類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 混合藥物釋放型支架
  • 混合生物分解性或金屬支架
  • 其他混合支架
  • 全球冠狀動脈支架市場細分（按藥物釋放型支架類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • Sirolimus洗脫支架
  • 紫杉醇洗脫支架
  • Everolimus洗脫支架
  • 佐他莫司洗脫支架
  • 其他藥物釋放型支架
  • 全球冠狀動脈支架市場裸金屬支架細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 不銹鋼裸金屬支架
  • 鈷鉻裸金屬支架
  • 其他裸金屬支架

第7章 區域和國家分析

  • 全球冠狀動脈支架市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球冠狀動脈支架市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 冠狀動脈支架市場：競爭格局
  • 冠狀動脈支架市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Terumo Corporation
  • WL Gore & Associates Inc.
  • Cook Medical Inc.
  • BIOTRONIK SE & Co. KG
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich
  • Asahi Intecc Co. Ltd.
  • Sahajanand Medical Technologies Limited
  • Translumina GmbH
  • Stentys SA
  • Sorin Group
  • InspireMD Inc.
  • CR Bard Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年冠狀動脈支架市場：提供新機會的國家
  • 2029年冠狀動脈支架市場：細分市場帶來新機會
  • 2029年冠狀動脈支架市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r29898

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $12.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $16.5 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, a report from the American College of Cardiology in August 2022 projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicted a 39.3% increase in diabetes cases to 55 million, a 27.6% rise in dyslipidemia to 126 million, a 25.1% increase in hypertension to 162 million, and an 18.3% rise in obesity to 126 million. The most notable increases are expected in stroke (33.8% rise to 15 million) and heart failure (33.4% rise to 13 million), with ischemic heart disease and heart attacks also showing substantial growth. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In October 2022, Cordis, a US-based developer of cardiovascular and endovascular devices, acquired MedAlliance for an undisclosed amount. This acquisition will enable Cordis to reach two million patients globally by 2027 with the SELUTION SLR (Sustained Limus Release) drug-eluting balloon. Cordis will also co-promote MedAlliance's SELUTION SLR drug-eluting balloon in existing markets. MedAlliance is a Switzerland-based manufacturer of coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
  • 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
  • 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
  • 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
  • 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
  • Subsegments:
  • 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
  • 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
  • 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
  • 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
  • 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
  • 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
  • 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
  • 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
  • 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc; Biosensors International Group Ltd.; Boston Scientific Corporation; B. Braun Melsungen AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coronary Stents Market Characteristics

3. Coronary Stents Market Trends And Strategies

4. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Coronary Stents Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Coronary Stents Market Growth Rate Analysis
  • 5.4. Global Coronary Stents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Coronary Stents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Coronary Stents Total Addressable Market (TAM)

6. Coronary Stents Market Segmentation

  • 6.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dual Therapy Stents
  • Radioactive Stents
  • Thrombectomy Stents
  • Covered Stents
  • Bioresorbable Stents
  • Biodegradable Stents
  • Hybrid Stents
  • Drug-Eluting Stents
  • Bare Metal Stents
  • 6.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Cutting
  • 3D-Printed Stents
  • Microfabrication
  • Nanotechnology-Based Stents
  • Electropolishing
  • Others Technologies
  • 6.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cobalt-Chromium
  • Stainless Steel
  • Platinum-Chromium
  • Nickel-Titanium
  • Polymer
  • 6.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Expandable Stents
  • Balloon-Expandable Stents
  • 6.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End Uses
  • 6.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sirolimus-Eluting Dual Therapy Stents
  • Paclitaxel-Eluting Dual Therapy Stents
  • Everolimus-Eluting Dual Therapy Stents
  • 6.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Beta Radiation Stents
  • Gamma Radiation Stents
  • Other Radiation Stents
  • 6.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Thrombectomy Stents
  • Mechanical Thrombectomy Stents
  • Hydrodynamic Thrombectomy Stents
  • 6.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PTFE-Covered Stents
  • ePTFE-Covered Stents
  • Polyurethane-Covered Stents
  • Other Covered Stents
  • 6.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Bioresorbable Stents
  • Metal-Based Bioresorbable Stents
  • Ceramic-Based Bioresorbable Stents
  • 6.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymeric Biodegradable Stents
  • Magnesium-Based Biodegradable Stents
  • Other Biodegradable Stents
  • 6.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hybrid Drug-Eluting Stents
  • Hybrid Biodegradable Or Metal Stents
  • Other Hybrid Stents
  • 6.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sirolimus-Eluting Stents
  • Paclitaxel-Eluting Stents
  • Everolimus-Eluting Stents
  • Zotarolimus-Eluting Stents
  • Other Drug-Eluting Stents
  • 6.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel Bare Metal Stents
  • Cobalt Chromium Bare Metal Stents
  • Other Bare Metal Stents

7. Coronary Stents Market Regional And Country Analysis

  • 7.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coronary Stents Market

  • 8.1. Asia-Pacific Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coronary Stents Market

  • 9.1. China Coronary Stents Market Overview
  • 9.2. China Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coronary Stents Market

  • 10.1. India Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coronary Stents Market

  • 11.1. Japan Coronary Stents Market Overview
  • 11.2. Japan Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coronary Stents Market

  • 12.1. Australia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coronary Stents Market

  • 13.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coronary Stents Market

  • 14.1. South Korea Coronary Stents Market Overview
  • 14.2. South Korea Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coronary Stents Market

  • 15.1. Western Europe Coronary Stents Market Overview
  • 15.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coronary Stents Market

  • 16.1. UK Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coronary Stents Market

  • 17.1. Germany Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coronary Stents Market

  • 18.1. France Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coronary Stents Market

  • 19.1. Italy Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coronary Stents Market

  • 20.1. Spain Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coronary Stents Market

  • 21.1. Eastern Europe Coronary Stents Market Overview
  • 21.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coronary Stents Market

  • 22.1. Russia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coronary Stents Market

  • 23.1. North America Coronary Stents Market Overview
  • 23.2. North America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coronary Stents Market

  • 24.1. USA Coronary Stents Market Overview
  • 24.2. USA Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coronary Stents Market

  • 25.1. Canada Coronary Stents Market Overview
  • 25.2. Canada Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coronary Stents Market

  • 26.1. South America Coronary Stents Market Overview
  • 26.2. South America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coronary Stents Market

  • 27.1. Brazil Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coronary Stents Market

  • 28.1. Middle East Coronary Stents Market Overview
  • 28.2. Middle East Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coronary Stents Market

  • 29.1. Africa Coronary Stents Market Overview
  • 29.2. Africa Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coronary Stents Market Competitive Landscape And Company Profiles

  • 30.1. Coronary Stents Market Competitive Landscape
  • 30.2. Coronary Stents Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Coronary Stents Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. W. L. Gore & Associates Inc.
  • 31.3. Cook Medical Inc.
  • 31.4. BIOTRONIK SE & Co. KG
  • 31.5. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.6. Meril Life Sciences Pvt. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. OrbusNeich
  • 31.9. Asahi Intecc Co. Ltd.
  • 31.10. Sahajanand Medical Technologies Limited
  • 31.11. Translumina GmbH
  • 31.12. Stentys S.A.
  • 31.13. Sorin Group
  • 31.14. InspireMD Inc.
  • 31.15. C. R. Bard Inc.

32. Global Coronary Stents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Stents Market

34. Recent Developments In The Coronary Stents Market

35. Coronary Stents Market High Potential Countries, Segments and Strategies

  • 35.1 Coronary Stents Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Coronary Stents Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Coronary Stents Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer